International collaborative research has analyzed Ebola virus genomes from the 2013–2016 outbreak, uncovering the role of factors such as language and distance between cities.
Browsing: Disease Area > Viral
Despite challenges and setbacks in the decades-long struggle to eradicate polio, effective vaccines, evidence-based policy and global cooperation have brought the world closer to achieving polio eradication than ever before.
Researchers have developed a transgenic mouse model to identify influenza A strains with the potential to cause a global pandemic.
In new research, the first live-attenuated Zika vaccine has been demonstrated to protected mice against the virus after a single dose.
Oral delivery of vaccines is an attractive approach but is hampered by a number of challenges. Here, the authors discuss the need to include immunostimulatory adjuvants in oral vaccines to overcome oral tolerance and elicit effector immune responses locally within the intestine.
Researchers have applied concepts from financial mathematical models to help predict the evolution of HIV proteins with the hope this could improve vaccine design.
Environmental change, and a growing and more connected population will promote vector-borne disease risk further. In this opinion piece, the authors discuss the role of climate modeling in disease prediction and epidemiology.
Researchers have identified the southern states of the USA as most at risk of high burden from Zika virus.
Researchers have demonstrated that both hepatitis B and hepatitis C infection are associated with an increased risk of Parkinson’s disease.
This opinion piece discusses the many challenges inherent in caring for HIV+ individuals with new-onset seizure. With more questions than answers in both resource-limited settings and more developed medical environments what do we need to elucidate going forwards?